secwatch.observer — SEC 8-K summary
======================================

Issuer:     Canopy Growth Corp (CGC)
CIK:        0001737927
Form:       8-K
Filed at:   2026-06-15T11:06:39+00:00
Accession:  0001193125-26-270277
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Canopy Growth Q4 revenue +10% to $71.2M; net loss narrows 21%; targets positive EBITDA in FY2027
--------------------------------------------------------------------------------

- Consolidated Q4 net revenue $71.2M (+10% YoY); full-year $284.6M (+6%).
- Canada medical cannabis Q4 revenue $25.3M (+27%); international markets Q4 $8.6M (+68%).
- Net loss from continuing operations narrowed 21% in Q4; adjusted EBITDA loss improved to $6.3M from $9.2M.
- Ended FY2026 with $131.3M net cash vs. $172.6M net debt at end of FY2025; free cash outflow improved to $69.1M.
- Guidance: expects positive adjusted EBITDA in FY2027; integration of MTL Cannabis ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737927/000119312526270277/0001193125-26-270277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737927/000119312526270277/cgc-20260615.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-270277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer